» Authors » Ryogo Minamimoto

Ryogo Minamimoto

Explore the profile of Ryogo Minamimoto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 157
Citations 1581
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito R, Kato K, Nanataki K, Abe Y, Ogawa H, Minamimoto R, et al.
EJNMMI Rep . 2025 Mar; 9(1):8. PMID: 40059276
Purpose: This study evaluates the performance of four large language models (LLMs) in classifying malignant lymphoma stages using the Lugano classification from free-text FDG-PET reports in Japanese Specifically, we assess...
2.
Minamimoto R, Abe Y, Kamiya S, Nakane T, Ito R, Kato K, et al.
Jpn J Radiol . 2025 Mar; PMID: 40038218
In pediatric oncology, F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) is valuable as a tool for noninvasive imaging and monitoring. While many reports have reviewed the use of PET and...
3.
Minamimoto R, Kato K, Naganawa S
Jpn J Radiol . 2024 Oct; 43(2):177-185. PMID: 39412643
Glucose is essential for muscle function and its uptake is influenced by aerobic conditions, hormonal regulations, and exercise. F-Fluorodeoxyglucose (FDG), a glucose analog used in PET/CT scans, can show incidental...
4.
Minamimoto R
Front Nucl Med . 2024 Oct; 1:796357. PMID: 39355641
Multiple myeloma (MM) is a hematologic malignancy characterized by infiltration of monoclonal plasma cells in the bone marrow (BM). The standard examination performed for the assessment of bone lesions has...
5.
Oikawa T, Saito K, Kurihara K, Horikawa D, Uruno K, Kajiwara H, et al.
Glob Health Med . 2024 Sep; 6(4):244-250. PMID: 39219587
The aim of this study is to estimate eye lens exposure dose when handling radiopharmaceuticals and interacting with patients receiving radiopharmaceuticals, and to verify the usefulness of X-ray protective goggles...
6.
Komatsu K, Kimura S, Kiryu Y, Watanabe A, Kinai E, Oka S, et al.
Glob Health Med . 2024 Jul; 6(3):174-182. PMID: 38947408
People living with human immunodeficiency virus (HIV) are at high risk of mental health problems. However, little is known about this risk in HIV-infected patients with hemophilia (HPH) who contracted...
7.
Kawai T, Taguchi S, Nozaki K, Kimura N, Oshina T, Iwaki T, et al.
Prostate Int . 2024 Jan; 11(4):239-246. PMID: 38196558
Background: In recent years, site-directed therapies (SDTs) targeting progressive lesions in patients with oligometastatic prostate cancer have attracted attention. However, whether they effectively treat oligoprogressive castration-resistant prostate cancer (CRPC) remains...
8.
Aso K, Gohda Y, Hotta M, Minamimoto R, Shimizu Y, Uemura Y, et al.
Ann Surg Oncol . 2023 Dec; 31(3):1990-1995. PMID: 38082170
Background: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is the standard treatment for patients with pseudomyxoma peritonei (PMP). In some malignancies, the standard uptake value of positron emission tomography with...
9.
Terakawa A, Tanabe A, Nakayama H, Minamimoto R
JCEM Case Rep . 2023 Nov; 1(5):luad111. PMID: 37908203
Metastatic pheochromocytoma and paraganglioma are incurable, and effective treatment of systemic symptoms resulting from catecholamine excess and local symptoms from tumor growth are crucial to prolong survival and improve quality...
10.
Ishida A, Kaneko K, Minamimoto R, Hotta M, Inoshita N, Takano K, et al.
J Neurosurg . 2023 Jul; 139(6):1671-1680. PMID: 37410630
Objective: Diagnosis and accurate localization of recurrent tumors in Cushing's disease (CD) are challenging, especially after multiple transsphenoidal surgeries (TSSs) or radiosurgery. Even experts face difficulties in detecting these recurrent...